Beck Mack & Oliver’s CVS Health CVS Stock Holding History

Beck Mack & Oliver’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21,248	Closed	-$1.69M	–	196
2025 Q4	$1.69M	Buy	21,248 +176	+0.8%	+$13.9K	0.03%	97
2025 Q3	$1.59M	Buy	21,072 +219	+1%	+$15K	0.03%	91
2025 Q2	$1.44M	Sell	20,853 -110	-0.5%	-$7.21K	0.03%	92
2025 Q1	$1.42M	Buy	20,963 +538	+3%	+$32.2K	0.03%	95
2024 Q4	$917K	Buy	20,425 +232	+1%	+$13K	0.02%	111
2024 Q3	$1.27M	Sell	20,193 -1,031	-5%	-$60.1K	0.02%	98
2024 Q2	$1.25M	Buy	21,224 +185	+0.9%	+$11.6K	0.03%	99
2024 Q1	$1.68M	Sell	21,039 -300	-1%	-$22.9K	0.03%	91
2023 Q4	$1.68M	Buy	+21,339	New	+$1.52M	0.04%	89
2023 Q1	–	Sell	-2,691	Closed	-$251K	–	171
2022 Q4	$251K	Hold	2,691	–	–	0.01%	157
2022 Q3	$257K	Hold	2,691	–	–	0.01%	152
2022 Q2	$249K	Hold	2,691	–	–	0.01%	157
2022 Q1	$272K	Hold	2,691	–	–	0.01%	167
2021 Q4	$278K	Hold	2,691	–	–	0.01%	170
2021 Q3	$228K	Hold	2,691	–	–	0.01%	195
2021 Q2	$225K	Hold	2,691	–	–	0.01%	188
2021 Q1	$202K	Sell	2,691 -325	-11%	-$23.7K	0.01%	178
2020 Q4	$206K	Buy	+3,016	New	+$196K	0.01%	184
2020 Q3	–	Sell	-3,271	Closed	-$213K	–	190
2020 Q2	$213K	Sell	3,271 -6,255	-66%	-$394K	0.01%	174
2020 Q1	$565K	Sell	9,526 -451	-5%	-$30.1K	0.03%	131
2019 Q4	$741K	Hold	9,977	–	–	0.02%	130
2019 Q3	$629K	Hold	9,977	–	–	0.02%	133
2019 Q2	$544K	Sell	9,977 -1,900	-16%	-$102K	0.02%	147
2019 Q1	$641K	Hold	11,877	–	–	0.02%	145
2018 Q4	$778K	Buy	11,877 +251	+2%	+$18.7K	0.03%	127
2018 Q3	$915K	Sell	11,626 -100	-0.9%	-$7.15K	0.03%	130
2018 Q2	$755K	Sell	11,726 -1,570	-12%	-$103K	0.03%	135
2018 Q1	$827K	Hold	13,296	–	–	0.03%	128
2017 Q4	$964K	Sell	13,296 -485	-4%	-$35.3K	0.03%	123
2017 Q3	$1.12M	Buy	13,781 +2,650	+24%	+$210K	0.04%	115
2017 Q2	$896K	Sell	11,131 -1,755	-14%	-$139K	0.03%	121
2017 Q1	$1.01M	Hold	12,886	–	–	0.04%	112
2016 Q4	$1.02M	Sell	12,886 -200	-2%	-$16.2K	0.04%	113
2016 Q3	$1.17M	Sell	13,086 -110	-0.8%	-$10.4K	0.04%	113
2016 Q2	$1.26M	Buy	13,196 +200	+2%	+$19.9K	0.04%	131
2016 Q1	$1.35M	Sell	12,996 -3,950	-23%	-$384K	0.05%	129
2015 Q4	$1.66M	Sell	16,946 -3,062	-15%	-$300K	0.06%	116
2015 Q3	$1.93M	Hold	20,008	–	–	0.06%	120
2015 Q2	$2.1M	Sell	20,008 -754	-4%	-$77K	0.05%	116
2015 Q1	$2.14M	Hold	20,762	–	–	0.05%	116
2014 Q4	$2M	Buy	20,762 +96	+0.5%	+$8.46K	0.05%	123
2014 Q3	$1.65M	Buy	20,666 +160	+0.8%	+$12.6K	0.04%	142
2014 Q2	$1.54M	Buy	20,506 +685	+3%	+$51.8K	0.03%	143
2014 Q1	$1.48M	Hold	19,821	–	–	0.03%	143
2013 Q4	$1.42M	Sell	19,821 -20,692	-51%	-$1.33M	0.03%	152
2013 Q3	$2.3M	Sell	40,513 -200	-0.5%	-$11.9K	0.06%	107
2013 Q2	$2.33M	Buy	+40,713	New	+$2.36M	0.06%	104

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Beck Mack & Oliver's CVS Position: Q1 2026 in Review

Beck Mack & Oliver sold out of CVS Health (CVS) in Q1 2026, closing a stake of 21,248 shares — an estimated $1.69M sold.

Beck Mack & Oliver first reported a position in CVS in Q2 2013 and held it in 47 quarters. The position peaked at $2.33M in Q2 2013. 1,876 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Beck Mack & Oliver reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
Beck Mack & Oliver sold 21,248 CVS Health shares in Q1 2026, an estimated $1.69M.
Beck Mack & Oliver first reported a position in CVS Health in Q2 2013 and held it in 47 quarters.
Beck Mack & Oliver's CVS Health position peaked at $2.33M in Q2 2013.
1,876 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Beck Mack & Oliver's 13F filing for Q1 2026, filed 12 May 2026.